Future challenges for health economics and health technology assessment of biological drugs László Gulácsi Editorial 18 April 2010 Pages: 235 - 238
BMI and Spanish labour status: evidence by gender from the city of Barcelona Toni Mora Original Paper 11 July 2009 Pages: 239 - 253
The impact of missing data in the estimation of concentration index: a potential source of bias Hai Zhong Original Paper 15 July 2009 Pages: 255 - 266
The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany Tom Stargardt Original Paper 29 July 2009 Pages: 267 - 277
Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes Yi-Wen TsaiYu-Wen WenYue-Chune Lee Original Paper 02 August 2009 Pages: 279 - 290
Principal agent relationships and the efficiency of hospitals Martijn LudwigFrits Van MerodeWim Groot Original Paper Open access 05 August 2009 Pages: 291 - 304
The welfare costs of HIV/AIDS in Eastern Europe: an empirical assessment using the economic value-of-life approach Julia FimpelMichael Stolpe Original Paper 05 August 2009 Pages: 305 - 322
Eliciting health state utilities from the general public for severe chronic pain S. EldabeA. LloydS. Dewilde Original Paper 13 August 2009 Pages: 323 - 330
Copayments for ambulatory care in Germany: a natural experiment using a difference-in-difference approach Jonas SchreyöggMarkus M. Grabka Original Paper 16 September 2009 Pages: 331 - 341
The Irish ‘health basket’: a basket case? Samantha Smith Pricing and reimbursement systems in Europe 05 August 2009 Pages: 343 - 350